Saturday 9 September 5:59:00 AM CET/ Friday 8 September 11:59 PM (US Eastern Daylight Time UTC -4)

 

Call for Proposals – Deadline to submit is Friday, September 8th 11:59 PM (US Pacific Standard Time UTC -8)

Publication: Selected abstracts will be published on an electronic media for distribution at the meeting and will be available online.

Previous Presentation of Abstracts: Abstracts ARE NOT considered for presentation if they were either published as an article or previously presented at a national or international meeting prior to the date of this presentation. Please be aware that submitted abstracts will be checked for plagiarism against previously published abstracts and articles using automated software.

Embargo Policy: Abstract results and presentations are prohibited from release until the SCMR designated embargo date and time. Failure to honor embargo policies will result in the abstract being withdrawn from presentation.

Conflict of Interest: If the research was partially or fully funded by a proprietary organization (e.g. pharmaceutical, biotech or device manufacture), you must describe the nature of the relationship. Example: “Research was funded in part by the XYZ Corporation, City, State.” Please do not list any authors with the disclosure text.

Grading: Abstracts are graded through a blind review. Authors should be cautious in using institutional references in the body of the abstracts. Do not put author names and affiliations in the body portion of the abstract.

Abstracts are selected on the basis of 1) Scientific merit: development or testing of a new idea or diagnostic procedure 2) Presentation: well organized, clear and concise 3) Technical quality: clearly presented data and facts with strong scientific backing.

Submission: When you have completed your online abstract form, click on Submit Abstract, but ONLY when you are sure that your abstract is complete and in final form.

Changes to Abstract after Submission: The EuroCMR/SCMR is not authorized to make changes to a submission. In order to correct your abstract, you must withdraw it and submit a new corrected version prior to the deadline by September 8, 2017, 11:59 PM, PST (See below for withdrawal procedure). Note that, such replacement of your abstract is not possible after the deadline Please carefully proofread abstracts to avoid errors before submission. If accepted, your abstract will be published EXACTLY as it was submitted.

Abstract Receipt Confirmation: If you submit on or before the deadline date, you will receive an email confirmation within two business days of submitting your abstract. If you submit on the deadline date and do not receive a confirmation within 48 hours, please contact programme@cmr2018.

Withdrawal
If you want to withdraw an abstract already submitted, please notify us as quickly as possible at programme@cmr2018.org stating the title and number of the abstract to be withdrawn.

Abstract Style: Remember that your abstract will appear EXACTLY as you submit it. Please check abstracts carefully for typographical errors, author listing, misspellings, poor hyphenation, etc.

Title: The title should be concise but long enough to clearly identify the nature of the study.

Abstract Structure: The body of the abstracts should be organized as follows: 

  • Introduction: Briefly describe the objectives of the study unless they are contained in the title. Include a hypothesis.
  • Methods: A brief description of the methods used.
  • Results: Describe findings in sufficient detail to support conclusions.
  • Conclusions: A concise statement summarizing study and conclusions reached.

Character and Word Count: There is a limit of 400 words (3,000 characters) for the text of your submission. The character count includes spaces. You will be advised of your character count usage throughout the submission process as you save and move to the next step. Your character and word count is displayed on the left hand side of your submission. The character count will not include title, authors, institutions, tables, and images.

Tables and Graphs: Simple tables and graphs may be included if they fit within the size constraints of the electronic program. Follow the instructions in the program for submitting graphs and use the table formatting function for table preparation.

Topics:

  • Arrhythmias
  • CAD/Ischemic Heart Disease
  • CAD Other
  • Cardiac Masses and Pericardial Disease
  • Clinical Outcome and Prognosis
  • Congenital Heart Disease and Pediatrics
  • Coronary Imaging
  • Cost Effectiveness and Comparison to Other Modalities
  • Early Career Award
  • Interventional Applications
  • Metabolism, Spectroscopy, and Hyperpolarized MRI
  • Miscellaneous
  • Molecular Imaging; Contrast Agents
  • Multi-Center Trials and Epidemiological Studies
  • New Techniques Ready for Clinical Application
  • Non-ischemic Primary and Secondary CMP
  • Post-Processing and Workflow
  • Pre-Clinical Validation of an Existing Technique
  • Rapid, Efficient Imaging
  • Valvular Heart Disease
  • Vascular MRI
  • Women’s Heart Disease

Under each topic please select the whether your abstract classifies as Basic Science, Translational or Clinical

Early Career Award (ECA) Abstract Submission Criteria

The Early Career Award is intended for clinical and basic scientists at the undergraduate, graduate, postgraduate, resident, and fellow levels working in MR research in clinical, industry, or research institutions (you can check the ECA criteria in the ECA section before submitting your abstract). 

Presentation Opportunities: Abstracts accepted for presentation will be assigned to one of the following session types:

  • Oral Abstract Session (9 sessions available) – The traditional oral abstract presentation session. 
  • Quick Fire Session (3 sessions available) – The Quick Fire Sessions are designed to allow attendees to rapidly overview a significant number of abstracts in a concentrated fashion. Authors will present their abstracts in 3-minute talks, highlighting only the more objective details. Immediately after the session, questions and more in-depth discussions will take place directly with the presenters during traditional poster presentations. 
  • Focus Session (7 sessions available) – The Focus Sessions will combine new scientific developments from abstract presentations with educational lectures tied by a central theme. Attendees will enjoy introductory lectures providing a technical and clinical background for the subject of the Session, followed by state-of-the-art developments presented by abstract authors. The addition of novelty abstract blocks to solid baseline talks should help build a rich teaching environment for the audience.
  • Moderated ePoster Session (12 sessions available) – The moderated ePoster sessions are moderated poster presentations presented to an audience on a video monitor. Presenting authors will be expected to be present at their poster and give a short oral overview on their work to moderators with a focus on results, followed by questions from the moderators.
  • Traditional Poster Session (3 sessions available) – The traditional poster presentation session.